Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Exponent (EXPO) over the last 16 years, with Oct 2025 value amounting to $207.4 million.

  • Exponent's Cash & Equivalents fell 5.61% to $207.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $207.4 million, marking a year-over-year decrease of 5.61%. This contributed to the annual value of $258.9 million for FY2025, which is 38.34% up from last year.
  • Exponent's Cash & Equivalents amounted to $207.4 million in Q4 2025, which was down 10.54% from $231.8 million recorded in Q3 2025.
  • Exponent's Cash & Equivalents' 5-year high stood at $297.7 million during Q4 2021, with a 5-year trough of $125.6 million in Q1 2023.
  • Over the past 3 years, Exponent's median Cash & Equivalents value was $203.3 million (recorded in 2024), while the average stood at $193.9 million.
  • Per our database at Business Quant, Exponent's Cash & Equivalents skyrocketed by 74.75% in 2021 and then crashed by 45.76% in 2022.
  • Exponent's Cash & Equivalents (Quarterly) stood at $297.7 million in 2021, then crashed by 45.76% to $161.5 million in 2022, then rose by 15.91% to $187.2 million in 2023, then soared by 60.25% to $219.7 million in 2024, then fell by 5.61% to $207.4 million in 2025.
  • Its Cash & Equivalents stands at $207.4 million for Q4 2025, versus $231.8 million for Q3 2025 and $245.1 million for Q2 2025.